These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6852973)
1. Melanoma-associated antigen p97 continues to be expressed after prolonged exposure of cells to specific antibody. Hellström I; Brown JP; Hellström KE Int J Cancer; 1983 May; 31(5):553-5. PubMed ID: 6852973 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity. Hellström I; Brown JP; Hellström KE J Immunol; 1981 Jul; 127(1):157-60. PubMed ID: 6787119 [TBL] [Abstract][Full Text] [Related]
3. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. Brown JP; Nishiyama K; Hellström I; Hellström KE J Immunol; 1981 Aug; 127(2):539-46. PubMed ID: 6166674 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antiidiotypic antibodies related to the p97 human melanoma antigen. Kahn M; Hellström I; Estin CD; Hellström KE Cancer Res; 1989 Jun; 49(12):3157-62. PubMed ID: 2470502 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Brown JP; Woodbury RG; Hart CE; Hellström I; Hellström KE Proc Natl Acad Sci U S A; 1981 Jan; 78(1):539-43. PubMed ID: 6165996 [TBL] [Abstract][Full Text] [Related]
6. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group. Hellström I; Brown JP; Hellström KE Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136 [TBL] [Abstract][Full Text] [Related]
7. Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97. Casellas P; Brown JP; Gros O; Gros P; Hellström I; Jansen FK; Poncelet P; Roncucci R; Vidal H; Hellström KE Int J Cancer; 1982 Oct; 30(4):437-43. PubMed ID: 7141740 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333 [TBL] [Abstract][Full Text] [Related]
9. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380 [TBL] [Abstract][Full Text] [Related]
10. Assignment of the gene for human melanoma-associated antigen p97 to chromosome 3. Plowman GD; Brown JP; Enns CA; Schröder J; Nikinmaa B; Sussman HH; Hellström KE; Hellström I Nature; 1983 May 5-11; 303(5912):70-2. PubMed ID: 6843660 [TBL] [Abstract][Full Text] [Related]
11. Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen. Liao SK; Khosravi MJ; Brown JP; Kwong PC Mol Immunol; 1987 Jan; 24(1):1-9. PubMed ID: 2441244 [TBL] [Abstract][Full Text] [Related]
12. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen. Imai K; Pellegrino MA; Wilson BS; Ferrone S Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235 [No Abstract] [Full Text] [Related]
13. Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97. Smith LM; Nesterova A; Alley SC; Torgov MY; Carter PJ Mol Cancer Ther; 2006 Jun; 5(6):1474-82. PubMed ID: 16818506 [TBL] [Abstract][Full Text] [Related]
14. Production and characterization of monoclonal antibodies against human malignant melanoma. Herlyn M; Steplewski Z; Herlyn D; Clark WH; Ross AH; Blaszczyk M; Pak KY; Koprowski H Cancer Invest; 1983; 1(3):215-24. PubMed ID: 6667406 [TBL] [Abstract][Full Text] [Related]
15. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens. Harper JR; Bumol TF; Reisfeld RA Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens. Saxton RE; Mann BD; Morton DL; Burk MW Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138 [TBL] [Abstract][Full Text] [Related]
17. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches. Morgan AC; Woodhouse C; Bartholemew R; Schroff R Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545 [TBL] [Abstract][Full Text] [Related]
18. Human melanoma-specific oncofetal antigen defined by a mouse monoclonal antibody. Liao SK; Clarke BJ; Khosravi M; Kwong PC; Brickenden A; Dent PB Int J Cancer; 1982 Nov; 30(5):573-80. PubMed ID: 7152720 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen. Bumol TF; Chee DO; Reisfeld RA Hybridoma; 1982; 1(3):283-92. PubMed ID: 6208129 [TBL] [Abstract][Full Text] [Related]
20. Detection of melanoma cells in bone marrow using monoclonal antibodies. A comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF). Dantas ME; Brown JP; Thomas MR; Robinson WA; Glode LM Cancer; 1983 Sep; 52(6):949-53. PubMed ID: 6349783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]